<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gago da Graca C</submitter><funding>Medical Research Council</funding><pagination>eadn1945</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7617396</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(103)</volume><pubmed_abstract>Stem-like T cells are attractive immunotherapeutic targets in patients with cancer given their ability to proliferate and differentiate into effector progeny. Thus, identifying T cells with enhanced stemness and understanding their developmental requirements are of broad clinical and therapeutic interest. Here, we demonstrate that during acute infection, the transcriptional regulator inhibitor of DNA binding 3 (ID3) identifies stem-like T cells that are uniquely adapted to generate precursors of exhausted T (Tpex) cells in response to chronic infection or cancer. Expression of ID3 itself enables Tpex cells to sustain T cell responses in chronic infection or cancer, whereas loss of ID3 results in impaired maintenance of CD8 T cell immunity. Furthermore, we demonstrate that interleukin-1 (IL-1) family members, including IL-36β and IL-18, promote the generation of ID3&lt;sup>+&lt;/sup> T cells that mediate superior tumor control. Overall, we identify ID3 as a common denominator of stem-like T cells in both acute and chronic infections that is specifically required to sustain T cell responses to chronic stimulation.</pubmed_abstract><journal>Science immunology</journal><pubmed_title>Stem-like memory and precursors of exhausted T cells share a common progenitor defined by ID3 expression.</pubmed_title><pmcid>PMC7617396</pmcid><funding_grant_id>MR/V009052/1</funding_grant_id><pubmed_authors>Kallies A</pubmed_authors><pubmed_authors>Shen J</pubmed_authors><pubmed_authors>Su CH</pubmed_authors><pubmed_authors>Bending D</pubmed_authors><pubmed_authors>Schroder J</pubmed_authors><pubmed_authors>Chisanga D</pubmed_authors><pubmed_authors>Gabriel SS</pubmed_authors><pubmed_authors>Nguyen MT</pubmed_authors><pubmed_authors>Shi W</pubmed_authors><pubmed_authors>Sheikh AA</pubmed_authors><pubmed_authors>Cluse LA</pubmed_authors><pubmed_authors>Singh J</pubmed_authors><pubmed_authors>Wen L</pubmed_authors><pubmed_authors>Vasanthakumar A</pubmed_authors><pubmed_authors>Mackay LK</pubmed_authors><pubmed_authors>Park SL</pubmed_authors><pubmed_authors>Utzschneider DT</pubmed_authors><pubmed_authors>Seow J</pubmed_authors><pubmed_authors>Cui W</pubmed_authors><pubmed_authors>Johnstone RW</pubmed_authors><pubmed_authors>Poch A</pubmed_authors><pubmed_authors>Newman DM</pubmed_authors><pubmed_authors>Burn TN</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Tsui C</pubmed_authors><pubmed_authors>Gago da Graca C</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Rausch L</pubmed_authors><pubmed_authors>Von Scheidt B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Stem-like memory and precursors of exhausted T cells share a common progenitor defined by ID3 expression.</name><description>Stem-like T cells are attractive immunotherapeutic targets in patients with cancer given their ability to proliferate and differentiate into effector progeny. Thus, identifying T cells with enhanced stemness and understanding their developmental requirements are of broad clinical and therapeutic interest. Here, we demonstrate that during acute infection, the transcriptional regulator inhibitor of DNA binding 3 (ID3) identifies stem-like T cells that are uniquely adapted to generate precursors of exhausted T (Tpex) cells in response to chronic infection or cancer. Expression of ID3 itself enables Tpex cells to sustain T cell responses in chronic infection or cancer, whereas loss of ID3 results in impaired maintenance of CD8 T cell immunity. Furthermore, we demonstrate that interleukin-1 (IL-1) family members, including IL-36β and IL-18, promote the generation of ID3&lt;sup>+&lt;/sup> T cells that mediate superior tumor control. Overall, we identify ID3 as a common denominator of stem-like T cells in both acute and chronic infections that is specifically required to sustain T cell responses to chronic stimulation.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2025-04-04T01:45:56.472Z</modification><creation>2025-04-04T01:45:56.472Z</creation></dates><accession>S-EPMC7617396</accession><cross_references><pubmed>39888981</pubmed><doi>10.1126/sciimmunol.adn1945</doi></cross_references></HashMap>